Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQAFY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On July 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order is expected to be completed by July 23, 2025, and represents a specific fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The vendor, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, competing on its merits within the open federal marketplace.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription medications and pharmacy services to Department of Defense healthcare facilities. The company's $499.9 billion Indefinite Delivery Contract with DLA, valid through November 2026, enables the issuance of firm fixed-price delivery orders across an extensive pharmaceutical portfolio including branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for Nuplazid—an antipsychotic medication—exemplifies the routine pharmaceutical procurement operations supporting military health systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FQAFY?
SPE2DB25FQAFY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 1, 2025.
How much is contract SPE2DB25FQAFY worth?
The government has obligated $3,459 on SPE2DB25FQAFY.
Is contract SPE2DB25FQAFY an order under another contract?
Yes. SPE2DB25FQAFY is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAFY competed?
The extent of competition for SPE2DB25FQAFY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award